iNtRON Biotechnology Inc

iNtRON Biotechnology Inc exhibits a strong liquidity position, with a current ratio of 10.72, indicating that the company holds significantly more current assets than current liabilities. The company's cash and equivalents amount to KRW 27,663,676,760, which is a substantial portion of its total assets of KRW 74,321,845,930. However, the company's liquidity is not supported by positive operating cash flow, which was negative at KRW -5,208,533,330 in the latest period. The company's profitability metrics are weak, with a return on equity (ROE) of -12.82% and a return on assets (ROA) of -12.05%. These figures indicate that the company is not generating returns for its shareholders or effectively utilizing its assets to generate profit. The operating income was negative at KRW -7,897,738,760, and the net income was also negative at KRW -8,958,475,730, reflecting a challenging financial performance. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification may expose the company to higher risks if demand in its primary market or product line declines. The company's revenue for the latest period was KRW 5,740,240,970. The company's growth trajectory is uncertain, as it reported a negative net income and negative operating cash flow. The company's capital expenditures were KRW -2,470,052,860, indicating a reduction in investment in long-term assets. The company's future revenue outlook is not explicitly provided, but the negative financial performance suggests a need for strategic adjustments to improve profitability and cash flow. The company's risk assessment indicates low liquidity and dilution risk, with no immediate filing-based liquidity or dilution flags detected. The company's debt-to-equity ratio is 0.05, suggesting a conservative capital structure with minimal reliance on debt financing. However, the company's negative operating cash flow and net income may limit its ability to service debt or fund operations without external financing. Recent events, including filings and transcripts, do not indicate any material changes in the company's financial position or strategic direction. The company's financial statements do not disclose any significant recent events that would impact its operations or financial performance.